IP Library Granted Patent US 7,851,229
Granted Patent B2
US 7,851,229 · App. 11/459,190 · Granted Dec 14, 2010

Two-phase optical assay with unitized container and double or single sensor systems

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,851,229
App. No.
11/459,190
Granted
Dec 14, 2010
Kind
B2
Abstract

Improved single-container, two-phase optical assays for analytes are provided which are faster and require less steps than conventional two phase optical assays. The assays of the invention involve first mixing and incubating an assay mixture including a buffer, solid particles (e.g., agarose beads), an analyte-containing sample, and an affinity agent operable to bind analyte(s) to the solid particles, followed by separation of the mixture into a particle-rich phase and a substantially particle-free phase. In one aspect, the settling step is gravity-induced and is instrumentally monitored to determine when substantially full separation has occurred. Thereafter, the respective phases may be photometrically measured to obtain qualitative and/or quantitative information about the analyte(s). It has been found that measurements taken with only one sensor set before and after settling of the particle-rich fraction give scientifically valid results as a two phase optical assay.

Claims (21)

1. A method of measuring at least one analyte in a sample, comprising the steps of:

incubating a mixture in a container, said mixture comprising a buffer, solid particles, said sample, and an affinity agent operable to bind the at least one analyte to said particles, and establishing a fully suspended phase where said particles are substantially uniformly distributed throughout said buffer;

gravitationally separating said incubated fully suspended phase in said container to give a particle-rich phase;

initially measuring a parameter of said at least one analyte in said fully suspended phase substantially at the beginning of the separating step, and subsequently measuring a parameter of said at least one analyte in said particle-rich phase at the end of the separating step, said initial and subsequent measuring steps each comprising directing electromagnetic radiation through said container; and

using said measurement parameters to calculate the proportional distribution of said at least one analyte in said fully suspended phase and in said particle-rich phase.

2. The method of claim 1 , including the step of maintaining said mixture within said container throughout all of the steps of the method.

3. The method of claim 1 , said incubation step comprising the step of repeatedly inverting said container with said mixture therein.

4. The method of claim 1 , including the step of monitoring said mixture during substantially the entirety of said separating step to determine the extent of phase separation thereof.

5. The method of claim 1 , said measurement parameters being selected from the group consisting of fluorescence intensity, fluorescence quenching, and radiation scattering.

6. The method of claim 1 , said analyte comprising a glycated protein.

7. The method of claim 6 , said glycated protein being glycated hemoglobin, said agent being an affinity agent for glycated hemoglobin.

8. The method of claim 1 , including the step of simultaneously measuring a plurality of analytes within said mixture.

9. The method of claim 8 , said plurality of analytes comprises hemoglobin variants.

10. The method of claim 9 , including the steps of using as said particles cation exchange particles within a plurality of different containers each having a buffer system with different salt concentrations.

11. The method of claim 10 , said cation exchange particles comprising carboxymethyl agarose, and said hemoglobin variants are selected from the group consisting of hemoglobin F, hemoglobin A, hemoglobin S, and hemoglobin C.

12. Method of claim 8 where the plurality of analytes includes an analyte from said sample and said fully suspended phase.

13. The method of claim 1 , said calculation step comprising the step of taking a ratio of said subsequent and initial parameters.

14. The method of claim 1 , including the steps of repetitively monitoring the separation of said incubated fully suspended phase until said particle-rich phase is established, in order to generate a plurality of intermediate measured parameters.

15. The method of claim 14 , including the steps of:

directing electromagnetic radiation through said container at a pair of vertically spaced apart locations in order to generate said plurality of intermediate measured parameters;

calculating a ratio of the first measurements in time at said vertically spaced apart locations, and using said ratio as a denominator with the remainder of said plurality of intermediate measured parameters until a final steady state is reached.

Assignments (2)
SECURITY AGREEMENT Recorded Jan 28, 2022
From: TRINITY BIOTECH, INC.; FITZGERALD INDUSTRIES INTERNATIONAL, INC.; CLARK LABORATORIES INC. (D/B/A TRINITY BIOTECH (USA)); BIOPOOL U.S., INC. (D/B/A TRINITY BIOTECH DISTRIBUTION); PRIMUS CORPORATION; IMMCO DIAGNOSTICS, INC.; MARDX DIAGNOSTICS, INC.
To: PERCEPTIVE CREDIT HOLDINGS III, LP
Reel/Frame 058890/0325 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2007
From: SAUNDERS, ALEXANDER MICHAEL
To: PRIMUS CORPORATION
Reel/Frame 019059/0516 →